Nyxoah Total Liabilities
Nyxoah total liabilities. Based on the latest financial reports, Nyxoah (NYXH) has total liabilities worth €42.65 Million EUR (≈ $49.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Nyxoah defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Nyxoah (2017–2024)
Total liabilities of Nyxoah from 2017 to 2024. This chart illustrates how Nyxoah's total liabilities have evolved over time, based on quarterly financial data. Check Nyxoah liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Nyxoah Competitors by Total Liabilities
The table below lists competitors of Nyxoah ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Osmanli Menkul Degerler AS
IS:OSMEN
|
Turkey | TL1.87 Billion |
|
Indo Thai Securities Limited
NSE:INDOTHAI
|
India | Rs657.61 Million |
|
RMB Holdings Ltd
JSE:RMH
|
South Africa | ZAC46.00 Million |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
USA | $35.52 Million |
|
Cords Cable Industries Limited
NSE:CORDSCABLE
|
India | Rs-2.02 Billion |
|
Fiyta Holdings Ltd
SHE:200026
|
China | HK$351.90 Million |
|
Lesico Ltd
TA:LSCO
|
Israel | ILA507.38 Million |
|
Odysight.ai Inc. Common Stock
NASDAQ:ODYS
|
USA | $3.99 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Nyxoah's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nyxoah balance sheet assets.
Liquidity & Leverage Metrics
Nyxoah Total Liabilities Ratios Explained
Nyxoah total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nyxoah's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nyxoah (2017–2024)
The table below shows the annual total liabilities of Nyxoah from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €45.15 Million ≈ $52.79 Million |
+72.76% |
| 2023-12-31 | €26.14 Million ≈ $30.55 Million |
+1.51% |
| 2022-12-31 | €25.75 Million ≈ $30.10 Million |
+15.94% |
| 2021-12-31 | €22.21 Million ≈ $25.96 Million |
+31.49% |
| 2020-12-31 | €16.89 Million ≈ $19.75 Million |
+47.10% |
| 2019-12-31 | €11.48 Million ≈ $13.42 Million |
+52.58% |
| 2018-12-31 | €7.53 Million ≈ $8.80 Million |
+13.71% |
| 2017-12-31 | €6.62 Million ≈ $7.74 Million |
-- |
About Nyxoah
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more